Noseworthy J - Search Results

1

Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures.

Matsumoto J, Morrow D, Kaufman K, Davis D, Ahlskog JE, Walker A, Sneve D, Noseworthy J, Rodriguez M. Matsumoto J, et al. Among authors: noseworthy j. Neurology. 2001 Nov 27;57(10):1876-82. doi: 10.1212/wnl.57.10.1876. Neurology. 2001. PMID: 11723279 Clinical Trial.

2

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M. Pittock SJ, et al. Among authors: noseworthy j. Ann Neurol. 2004 Aug;56(2):303-6. doi: 10.1002/ana.20197. Ann Neurol. 2004. PMID: 15293286

3

Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.

Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Pittock SJ, et al. Among authors: noseworthy jh. Arch Neurol. 2004 May;61(5):679-86. doi: 10.1001/archneur.61.5.679. Arch Neurol. 2004. PMID: 15148144

4

The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis.

Noseworthy JH, O'Brien P, Erickson BJ, Lee D, Sneve D, Ebers GC, Rice GP, Auty A, Hader WJ, Kirk A, Duquette P, Carter J, Francis G, Metz L, Shuster E. Noseworthy JH, et al. Neurology. 1998 Nov;51(5):1342-52. doi: 10.1212/wnl.51.5.1342. Neurology. 1998. PMID: 9818858 Clinical Trial.

5

A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis.

Noseworthy JH, O'Brien PC, Petterson TM, Weis J, Stevens L, Peterson WK, Sneve D, Cross SA, Leavitt JA, Auger RG, Weinshenker BG, Dodick DW, Wingerchuk DM, Rodriguez M. Noseworthy JH, et al. Neurology. 2001 Jun 12;56(11):1514-22. doi: 10.1212/wnl.56.11.1514. Neurology. 2001. PMID: 11402108 Clinical Trial.

6

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Mayr WT, et al. Among authors: noseworthy jh. Neurology. 2003 Nov 25;61(10):1373-7. doi: 10.1212/01.wnl.0000094316.90240.eb. Neurology. 2003. PMID: 14638958

7

Use of motion analysis for quantifying movement disorders.

Kaufman KR, Shaughnessy WJ, Noseworthy JH. Kaufman KR, et al. Among authors: noseworthy jh. Adv Neurol. 2001;87:71-81. Adv Neurol. 2001. PMID: 11347245 Review. No abstract available.

8

Not every patient with multiple sclerosis should be treated at time of diagnosis.

Pittock SJ, Weinshenker BG, Noseworthy JH, Lucchinetti CF, Keegan M, Wingerchuk DM, Carter J, Shuster E, Rodriguez M. Pittock SJ, et al. Among authors: noseworthy jh. Arch Neurol. 2006 Apr;63(4):611-4. doi: 10.1001/archneur.63.4.611. Arch Neurol. 2006. PMID: 16606780 No abstract available.

9

MRI findings in benign multiple sclerosis are variable.

Pittock SJ, Noseworthy JH, Rodriguez M. Pittock SJ, et al. Among authors: noseworthy jh. J Neurol. 2007 Apr;254(4):539-41. doi: 10.1007/s00415-006-0276-y. Epub 2006 Aug 29. J Neurol. 2007. PMID: 16944348 No abstract available.

10

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M. Weinshenker BG, et al. Among authors: noseworthy jh. Ann Neurol. 1999 Dec;46(6):878-86. doi: 10.1002/1531-8249(199912)46:6<878::aid-ana10>3.0.co;2-q. Ann Neurol. 1999. PMID: 10589540 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters